Showing results (181-190 of 193) with videos related to
Sort By:
Pageof 20
Acta Neuropathologica|June 6, 2022
DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastomaSebastian Adeberg, Maximilian Knoll, Christian Koelsche, et al.Cancers|April 18, 2019
Identification of KIF11 As a Novel Target in MeningiomaGerhard Jungwirth, Tao Yu, Mahmoud Moustafa, et al.Science Translational Medicine|March 4, 2026
Drug screening on tumor organoids exposes therapeutic vulnerabilities of meningiomas to HDAC1/2i panobinostatGerhard Jungwirth, Junguo Cao, Yimin Pan, et al.Frontiers in Psychology|January 3, 2022
Screening and Psycho-Oncological Support for Patients With Head and Neck Cancer and Brain Malignancies Before Radiotherapy With Mask Fixation: Results of a Feasibility StudySebastian Adeberg, Christina Sauer, Lena Lambert, et al.Acta Neuropathologica|March 24, 2017
Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimensCarmen Rapp, Rolf Warta, Slava Stamova, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in MeningiomasCarmen Rapp, Steffen Dettling, Fang Liu, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 21, 2020
Diagnostic Accuracy of <sup>18</sup>F-PSMA-1007 PET/CT Imaging for Lymph Node Staging of Prostate Carcinoma in Primary and Biochemical RecurrenceKatharina Sprute, Vasko Kramer, Stefan A Koerber, et al.Cancer Cell|September 10, 2021
Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasionYan Lan, Mahmoud Moustafa, Maximilian Knoll, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2023
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/mlNantia Solomonidou, Daphnie Germanou, Iosif Strouthos, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 15, 2025
The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 <sup>68</sup>Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient managementFrederik L Giesel, Stefan A Koerber, Boris Hadaschik, et al.Pageof 20